Multifunctional 3D Bioelectronic and Microfluidic Hybrid Systems for Online Monitoring, Regulation, and Vascularization of Organoids
Project Number5R21EB033495-03
Contact PI/Project LeaderWANG, XUEJU
Awardee OrganizationUNIVERSITY OF CONNECTICUT STORRS
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Human organoids are miniaturized model systems of organs produced by three-dimensional (3D) cultures of
tissue-resident-adult stem cells (ASCs) or pluripotent stem cells (PSCs) in vitro. They have emerged as a
promising platform for modeling tissue development and disease, personalized medicine development, drug
screening and drug toxicity investigations. Despite their great potential, current human organoids suffer from
immature structure and functionality, limited heterogeneity, as well as limited accessible readouts for organoid
evaluation. For example, detailed investigations of these 3D biosystems, such as 3D electrophysiological
mapping for brain and heart organoids, cannot be achieved using conventional approaches such as two-
dimensional (2D) multi-electrode arrays (MEAs) for modulation and multimodal sensing. Furthermore, most
current biosystems lack stable and mature vascularization that exists in vivo, which poses challenges to
controlled delivery of oxygen, nutrition, and molecules like neural patterning factors to enhance organoid size,
lifespan, and complexity. Our goal is to develop a soft electronic/microfluidic hybrid 3D network for online
monitoring, regulation, and vascularization of human organoids. The resulting system will integrate separately
addressable electrical, optical, electrochemical, and thermal sensors and stimulators of designated locations
with 3D biomimetic microvascular networks for simultaneous sensing, stimulation, and well-controlled delivery
of molecules into deep tissues to study tissue development and modulation. We will achieve this goal through
pursuing three specific aims: (1) Develop multifunctional 3D electronic networks with high spatiotemporal
resolution for online monitoring and regulation of organoid function, (2) Develop biomimetic 3D microvascular
networks for the vascularization of 3D tissues and integrate them with 3D electronic networks into a hybrid
system, and (3) Evaluate the efficiency and functional robustness of the integrated system in vitro using brain
organoids as an example. Our proposed multifunctional hybrid system incorporates the following notable
innovative features: 1) Soft, stretchable 3D networks for electrical, optical, electrochemical, and thermal sensing
and stimulation of human organoids, 2) Biomimetic 3D microvascular networks for the vascularization of human
organoids, 3) Fully integrated electronics and microfluidics networks as a micro-lab for investigating various
induced and natural behaviors of human organoids. This work will create a new route to study neurodevelopment
and neurological disorders through simultaneous monitoring, regulation, and vascularization of brain organoids
throughout their 3D interior, which is of broad potential interest to the neuroscience community. In addition, the
developed 3D hybrid system can be applied to other types of organoids, including heart, lung, and kidney for in
vitro studies of related diseases.
Public Health Relevance Statement
PROJECT NARRATIVE
The proposed research is relevant to public health because it focuses on developing new technologies for the
investigation of tissue development and disease such as Alzheimer's disease, personalized medicine, and drug
screening. This study will yield a soft, multifunctional electronic/microfluidic hybrid platform in 3D geometries for
online monitoring, regulation, and vascularization of human organoids produced by three-dimensional (3D)
cultures of tissue-resident-adult stem cells or pluripotent stem cells.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
614209054
UEI
WNTPS995QBM7
Project Start Date
01-September-2022
Project End Date
31-May-2026
Budget Start Date
01-June-2024
Budget End Date
31-May-2026
Project Funding Information for 2024
Total Funding
$195,949
Direct Costs
$139,200
Indirect Costs
$56,749
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$195,949
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21EB033495-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21EB033495-03
Patents
No Patents information available for 5R21EB033495-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21EB033495-03
Clinical Studies
No Clinical Studies information available for 5R21EB033495-03
News and More
Related News Releases
No news release information available for 5R21EB033495-03
History
No Historical information available for 5R21EB033495-03
Similar Projects
No Similar Projects information available for 5R21EB033495-03